Insights On Clinical Technologies

  1. How An AI/ML Data Strategy Can Deliver Better Business Outcomes 2/22/2022

    Discover how data science and artificial intelligence and machine learning driven predictive and prescriptive insights can help research teams cut the time and cost.

  2. The Impact Of Inclusion/Exclusion Criteria On Clinical Trial Diversity 5/13/2023

    The industry is aware of the racial and ethnic imbalance in clinical trials and its consequences. Discover how inclusive trial design can lead to better patient outcomes and more representative results.

  3. Gradually Investing In Direct Data Capture Is Inevitable 2/2/2023

    Given the decentralization of clinical trials and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”

  4. The Platform Shift is Here: Are you Realizing ROI Across your Portfolio of Studies? 9/20/2022

    Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.

  5. Maximizing The Value Of External Data 6/28/2023

    Gain valuable insights into the effective management of external data and how to implement best practices to achieve maximum value.

  6. Increase Participant Diversity With eClinical Tools 4/14/2023

    The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.

  7. How eConsent Can Help Legally Authorized Representatives In Clinical Trials 6/22/2022

    In this article, explore the three ways eConsent can help a legally authorized representative (LARs).

  8. eConsent: The Missing Ingredient To More Engaging Clinical Trials 8/29/2022

    Electronic consent products set the stage for a better trial experience for all stakeholders, but many sites and sponsors are wary of giving up their paper-based past.

  9. Clinical Research In 2035: What Can We Expect? 3/21/2022

    Derk Arts, Founder and CEO of Castor, and Kimberly Tableman, Castor’s Chief Clinical Development Officer, discuss what changes are expected in clinical research, technology, and data through the lens of three key pillars.

  10. TMF Services Buyers Guide 10/29/2021

    If you’re looking for TMF services support but don’t know where to start, this guide can help you ask the right questions and select a partner who understands your organization, supports your goals and objectives, and assists in maintaining constant TMF inspection readiness.